INNOVATIVE CLINICAL SOLUTIONS LTD
10-K, EX-10.23, 2000-06-01
MISC HEALTH & ALLIED SERVICES, NEC
Previous: INNOVATIVE CLINICAL SOLUTIONS LTD, 10-K, EX-10.22, 2000-06-01
Next: INNOVATIVE CLINICAL SOLUTIONS LTD, 10-K, EX-10.24, 2000-06-01



<PAGE>


                                                                 Exhibit 10.23

August 9, 1999

Mr. Gary Gilheeney
4 Caraway Drive
Johnston, RI  02919

Dear Gary:

We are very pleased to extend an offer of employment to you for the position of
Chief Financial Officer and Treasurer of Innovative Clinical Solutions. The
terms are as follows:

         Base Salary:        $175,000

         Sign-On Bonus       $10,000

         Bonus Potential:    25% bonus potential (based on both company division
                             and personal performance metrics).

         Equity:             a.  An initial grant of 100,000 shares at market
                             price.

                             b. Options will be vested over a three year period
                             in equal increments. If there is a material change
                             in ownership of the company, all outstanding
                             options will vest with change of control.

         Benefits:           Innovative Clinical Solutions policies

         Severance:          A. One year of base compensation and payment of
                             COBRA premiums for termination by the company
                             without cause.

                             or

                             B. One year base compensation and payment of COBRA
                             premiums as a result of a material change in
                             responsibilities, reporting relationships or
                             location.

These terms are contingent upon the successful completion of referencing.

We are very excited about the prospect of working with you and look forward to
you joining our team on August 23, 1999. Please sign and return this letter as
your acceptance of these terms.

Best Regards,

Michael Heffernan

I acknowledge and agree to the terms stated above.

Gary Gillheeney


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission